Pharma Journalist - Page 888 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Acasti Pharma invited to present the CaPre study results at National Lipid Association Scientific Sessions

XOMA Earns $10 Million Milestone Payment as Another of its Licensed Assets

FDA approves Jubilant’s Amlodipine and Olmesartan Medoxomil Tablets

FDA expands approved use of Kalydeco to treat cystic fibrosis

FDA grants Octapharma orphan drug designation for Octagam 10%

Lilly selects Cogstate as preferred provider for Alzheimer Disease Platform

Concert Pharmaceuticals Announces Clinical Hold on CTP-543

CytoDyn’s PRO 140 treats patient suffering from GvHD in Phase 2 trial

FDA approves Launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market

Dr. Donna Morgan Murray appointed as Nativis Chief Regulatory Officer